Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Adis R&D Insight Sue Shoolbread Editorial Leader 12 June 2006 What’s New • R&D Insight for Chemists • Business Development & Licensing Insight • ↑ Coverage of Scientific/Clinical Research that Supports Regulatory Submission • Customized Solutions R&D Insight for Chemists • Collaboration with CambridgeSoft - providers of ChemDraw software • Draw chemical structures using ChemDraw and query R&D Insight to find related molecules • Search by structure, sub-structure, names, partial names & synonyms • Link to full R&D Insight drug profiles (requires R&D Insight subscription) Business Development & Licensing Insight • To assist pharma companies identify & evaluate early-stage assets for in-licensing or partnering • Profiles of the most significant early stage innovations by institutions and biotechs • Includes novel drug therapies, diagnostics, devices, drug delivery systems & technology platforms • Will be delivered to the AdisInsight platform Scientific Coverage • Focus on research that supports active drug development & regulatory submission • ↑ in-depth conference coverage (top 100 scientific meetings) → more timely inclusion in R&D Insight • ↑ links to full clinical trial assessments of best evidence from Clinical Trials Insight • Use of ongoing trial registries for early notification of clinical trial progress. Customized Solutions • Answers, not just more information • Deliver customized competitive intelligence • In-depth product profiles and competitive product positioning • Respond to one-time strategic questions • Put therapy and market data into context • Provide high-level or detailed indication or therapeutic area overviews • How can we support you? R&D Insight – Sneak Peek • Links to full text of source data – Clinical trial assessments, linking to original papers via OVID – Media releases – Original research articles, via OVID R&D Insight – Sneak Peek • Content/Search Functionality – – Thesaurus Upgrade, particularly Class & Mechanism of Action terms – Better categorization of company relationships (major editorial project) – More tabulation of data to aid searching., eg company agreements – Alternative results views – user determined